Hydroxyprogesterone

CAS No. 68-96-2

Hydroxyprogesterone ( 17A-Hydroxyprogesterone; Hydroxyprogesterone )

Catalog No. M15637 CAS No. 68-96-2

17-Hydroxyprogesterone (17-OHP) is an endogenous progestogen as well as chemical intermediate in the biosynthesis of other steroid hormones.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 45 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hydroxyprogesterone
  • Note
    Research use only, not for human use.
  • Brief Description
    17-Hydroxyprogesterone (17-OHP) is an endogenous progestogen as well as chemical intermediate in the biosynthesis of other steroid hormones.
  • Description
    17-Hydroxyprogesterone (17-OHP) is an endogenous progestogen as well as chemical intermediate in the biosynthesis of other steroid hormones, including the corticosteroids and the androgens and the estrogens.
  • Synonyms
    17A-Hydroxyprogesterone; Hydroxyprogesterone
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    ER
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    68-96-2
  • Formula Weight
    330.47
  • Molecular Formula
    C21H30O3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 40mg/mL
  • SMILES
    O=C1CC[C@]2(C)[C@@]3([H])CC[C@]4(C)[C@@](O)(C(C)=O)CC[C@@]4([H])[C@]3([H])CCC2=C1
  • Chemical Name
    (8R,9S,10R,13S,14S,17R)-17-Acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Boonyaratanakornkit V, et al. Mol Endocrinol. 2007 Feb;21(2):359-75.
molnova catalog
related products
  • Methyl Isoferulate

    This product is isolated and purified from the leaves of Phyllostachys heterocycla.

  • Ulipristal acetate

    Ulipristal acetate(CDB2914) is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma.

  • XCT790

    A potent and selective ERRα inverse agonist with IC50 of 300-500 nM in transient transfection assays.